loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Jul 24, 2026

loader2

Open ICICI 3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

What is Nifty 200?

Company Name PE Mcap/Sales P/BV EV/EBIDTA D/E ROCE ROE
Abbott India Ltd 39.34 8.77 12.77 32.40 0.04 43.78 34.46
Cipla Ltd 33.55 2.89 3.27 22.59 0.02 15.66 11.79
Dr Reddys Laboratories Ltd 30.58 2.89 2.56 16.43 0.17 13.65 11.64
Lupin Ltd 20.46 3.92 4.88 14.84 0.30 27.44 27.01
Torrent Pharmaceuticals Ltd 90.12 10.00 22.91 44.98 1.14 18.30 26.76
Ipca Laboratories Ltd 37.96 4.66 5.57 24.31 0.14 19.01 15.87
Sun Pharmaceutical Industries Ltd 40.73 8.02 5.61 29.26 0.04 18.72 14.85
Aurobindo Pharma Ltd 25.27 2.79 2.34 14.58 0.24 14.16 11.15
Wockhardt Ltd 150.95 8.91 6.08 76.62 0.46 7.79 5.81
Ajanta Pharma Ltd 40.71 7.88 9.49 30.57 0.04 31.81 25.39
Gland Pharma Ltd 38.18 6.98 3.79 26.79 0.04 11.67 7.82
Biocon Ltd 192.52 4.19 2.06 33.93 0.61 3.76 1.34
Alkem Laboratories Ltd 28.51 5.17 4.85 27.33 0.13 20.03 19.88
Glenmark Pharmaceuticals Ltd 45.70 4.67 5.92 35.10 0.22 18.48 15.79
Zydus Lifesciences Ltd 21.68 2.17 4.10 17.83 0.31 20.30 19.69
Divis Laboratories Ltd 75.49 18.36 11.57 60.85 0.00 21.00 16.19
Mankind Pharma Ltd 54.49 7.40 6.48 29.99 0.48 12.97 12.65
Laurus Labs Ltd 95.16 12.44 15.99 57.64 0.54 16.70 18.21
Sai Life Sciences Ltd 75.43 15.54 10.60 67.39 0.41 13.82 10.97
Piramal Pharma Ltd -73.82 2.71 2.95 53.98 0.65 2.48 -3.83

Other Indices

INDEX NAME MARKET VALUE 52W HIGH 52W LOW
Nifty Next 50 71766.0
(-0.1036%)
73141.05 59896.10
Nifty Bank 56693.50
(0.1794%)
61764.85 49954.85
Nifty 50 23767.45
(-0.4280%)
26373.20 22182.55
Nifty 100 24840.75
(-0.3680%)
26975.15 22720.45
BSE SmallCap 46825.31
(0.0%)
55414.63 46731.72
BSE Sensex 76059.77
(-0.4341%)
86159.02 71545.81
BSE MidCap 44246.27
(0.0%)
47764.30 43806.95
BSE 100 25372.53
(-0.3155%)
27621.72 23249.92

Nifty Pharma

The NIFTY Pharma Index reflects the behaviour and performance of the pharmaceutical sector in India. The index has a maximum of 20 stocks since the last amendment effective from 30th September 2021. The NIFTY Pharma stocks are calculated using the free-float market capitalization method and can be used for benchmarking fund portfolios, among other utilization for investors. The index was launched in July 2005; the base date being 1st January 2001 with a base value of 1000. Index is re-balanced on semi-annual basis. The cut-off date is January 31 and July 31 of each year. When rebalancing, the weightage of each stock in the index is calculated such that no single stock has a weightage of more than 33%, and that of top 3 stocks cumulatively shall not be more than 62%.

News

UltraTech Cement fixes record date for dividend

UltraTech Cement has fixed 30 July 2026 as record date for purpose of determining eligibility of dividend...

Jul 24, 2026 19:32
Container Corporation Of India fixes record date for interim dividend

Container Corporation Of India has fixed 04 August 2026 as record date for purpose of interim dividend f...

Jul 24, 2026 19:30
Polyplex Corporation fixes record date for final dividend

Polyplex Corporation has fixed 08 September 2026 as record date for final dividend of Re 1 per equity sha...

Jul 24, 2026 19:28
Bondada Engineering fixes record date for final dividend

Bondada Engineering has fixed 14 August 2026 as record date for purpose of final dividend. ...

Jul 24, 2026 13:42
NSE adds Ather Energy, Bank of Maharashtra and Sagility to F&O segment

The National Stock Exchange (NSE) on Thursday said it will introduce futures and options (F&O) contracts ...

Jul 24, 2026 09:36
Bata India fixes record date for interim dividend

Bata India has fixed 19 August 2026 as record date for purpose of interim dividend for FY 2027....

Jul 23, 2026 15:11
Disclaimer

ICICI Securities Ltd. Registered office of ICICI Securities is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Mumbai - 400025, India, Tel No:- 022 - 2288 2460, 022 - 2288 2470. ICICI Securities is a Member of National Stock Exchange of India Ltd (Member Code:-07730) and BSE Ltd (Member Code :103) and having SEBI registration no. INZ000183631. SEBI research analyst Registration no.-INH000000990. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  ICICI Securities and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The non-broking products / services like Mutual Funds, Insurance, FD/ Bonds, loans, PMS, Tax, Elocker, NPS, IPO, Research, Financial Learning etc. are not exchange traded products / services and ICICI Securities Ltd. is just acting as a distributor/ referral Agent of such products / services and all disputes with respect to the distribution activity would not have access to Exchange investor redressal or Arbitration mechanism.